Evidence map›Paper›PMID 41640976›Full record

ArticleJVS-vascular science2026

Proteomic signatures of carotid plaque vulnerability: Proteolysis, inflammation, metabolic reprogramming, and lipid dysregulation.

Camilo Polania Sandoval, James F Meschia, Mercedes Prudencio, Tania Gendron, Christopher Jacobs, Richard D Beegle, Sukhwinder J S Sandhu, Kiran K Mangalaparthi, Jaeyun Sung, Xiaowei Zhao and 5 more

Abstract read
In one paragraph

Article in JVS-vascular science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Camilo Polania SandovalDivision of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL.
James F MeschiaDepartment of Neurology, Mayo Clinic, Jacksonville, FL.
Mercedes PrudencioDepartment of Neurosciences, Mayo Clinic, Jacksonville, FL.
Tania GendronDepartment of Neurosciences, Mayo Clinic, Jacksonville, FL.
Christopher JacobsDivision of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL.
Richard D BeegleDepartment of Radiology, Mayo Clinic, Jacksonville, FL.
Sukhwinder J S SandhuDepartment of Radiology, Mayo Clinic, Jacksonville, FL.
Kiran K MangalaparthiDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Jaeyun SungDivision of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
Xiaowei ZhaoBioinformatics and Computational Biology Program, University of Minnesota, Rochester, MN.
Aziza NassarDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL.
Houssam FarresDivision of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL.
Leonard PetrucelliDepartment of Neurosciences, Mayo Clinic, Jacksonville, FL.
Akhilesh PandeyCenter of Individualized Medicine, Mayo Clinic, Rochester, MN.
Young ErbenDivision of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Carotid plaque vulnerability is a current feature that aids in the decision-making for ischemic stroke risk. Proteomic analysis of plaque tissue can reveal molecular indicators of instability that complement imaging findings. We sought to identify a proteomic signature distinguishing vulnerable from stable carotid plaques in patients undergoing endarterectomy, with the aim of uncovering candidate biomarkers for potential diagnostic and therapeutic targets. Methods: Twenty-eight carotid plaque specimens were collected from 27 patients (including 1 patient with bilateral endarterectomy). Samples were classified as vulnerable (n = 14) or nonvulnerable (n = 14) based on preoperative magnetic resonance angiography with vessel wall imaging. A tandem mass tag-based multiplexing strategy followed by mass spectrometric analysis was used to profile the proteomes of all samples. Normalized and log Results: From 3267 proteins identified, 398 reached nominal significance ( Conclusions: Our proteomic profiling delineates a robust vulnerability signature marked by enhanced proteolysis, neutrophil activation, inflammatory signaling, metabolic reprogramming, and lipid dysregulation. High-confidence proteins emerged as tissue biomarkers of plaque instability. Validating their association with future cerebrovascular events is the next step toward clinically actionable stroke prediction. Exploratory candidates warrant further analysis.

Indexed as

Carotid artery diseaseProteomicsRisk stratificationStrokeVulnerable features

Identifiers

PMID41640976
PMCPMC12865546

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.